Explore new technological advances like the enhancement of next-generation sequencing (NGS) technologies, chromosomal microarray analysis (CMA) tools, and PCR TaqMan. Take an in-depth look at the major vendors offering tests, their industry concentration, and growth strategies.
Why does this sector play an important role in the treatment of chronic medical conditions such as diabetes? How is the uptake of clinical technologies like EMR and virtual care? Analyze key growth prospects from areas like AI, interoperability, and transitional/home care.
Examine major developments in this landscape, like the utilization of conventional and emerging clinical applications. Also, analyze the factors influencing RoI, critical unmet needs and potential game-changing strategies, opportunities for fixed IXR and surgical C-arm systems, technologies, and more.
From raw materials sourcing to production and final delivery, the journey of a product in today’s global supply chain is rife with environmental and societal issues. Excessive energy and water consumption, high waste production with low reuse rates, human rights issues, and abuse of labor are just some of the core issues plaguing supply chains globally. A supply chain is a vast network between large companies and their suppliers to develop, manufacture and distribute finished products to end users. More companies are becoming increasingly aware that their supply chain and sourcing decisions have a critical impact, not just on the environment but on society as well.
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
Analyze the increased consolidation and high-impact acquisitions in this landscape
Read more Request Info
How can vendors create solutions focusing on decentralized and virtual hybrid tests?
Read more Request Info
What are the key drivers for outsourcing nonclinical and clinical development?
Read more Request Info
Explore segments like X-rays, ultrasound, mammography, MRI, and IT solutions
Read more Request Info
How is this sector used for vital sign monitoring and physiological parameter tracking?
Read more Request Info
Examine the impact of CGT success in prevalent diseases like diabetes and stroke
Read more Request Info
Why are original equipment manufacturers in this space making certain parts disposable?
Read more Request Info
What are the key approvals, M&As, product licensing deals, and digital partnerships?
Read more Request InfoThe need to alleviate pressure on healthcare professionals and increase patient care time boosts the demand for medical device connectivity (MDC), according to Frost & Sullivan’s recent analysis of the global MDC industry. MDC helps overcome staffing challenges in organizations as data from medical devices is added to patients’ electronic records without manual entry. The promising market for global MDC is expected to hit $8.96 billion by 2027 from $2.47 billion in 2022, registering a compound annual growth rate (CAGR) of 29.4%.
Read more
Breast cancer is now the most diagnosed cancer and the leading cause of death among women. According to the World Health Organization and the World Cancer Research Fund, breast cancer is the world’s second most common form of cancer; in 2020, an estimated 2.3 million new cases were diagnosed, and 685,000 lives were lost globally. This #BreastCancerAwareness Month, we hope to do our part and continue to throw light on the enormity of this disease.
Read more
The adoption of cloud technology in healthcare is on the rise. Frost & Sullivan’s Global Cloud User Survey, Q4 2021 points to 43% of healthcare respondents agreeing that a cloud strategy was essential to remaining competitive, while 41% strongly agreed with the statement that the cloud is the most important part of a digital transformation strategy; 75% agreed that the cloud was crucial or extremely important for achieving healthcare business goals. Clearly, the cloud is an important technology for healthcare’s future. But how is the technology helping achieve public health goals, especially in a country like India, which is now emerging as an eager adopter of healthcare technologies?
Read more
Frost & Sullivan recently analyzed the global medical devices connectivity industry and, based on its research findings, recognizes Ascom with the 2022 Global Medical Devices Connectivity Technology Innovation Leadership Award. The company provides a vendor-neutral Medical Device Integration (MDI) platform that adapts to and integrates with any vendor’s bedside medical device through a variety of interfaces to collect data and events. Ascom offers serial MDI using a new, innovative, and dedicated magnetic connector and related plug that easily collects and integrates data while enhancing workflows. This provides a unique solution for devices that frequently move from one bed to another and are prone to bending and breaking pins within the connection cables. The automatic identification of integrated medical devices also enables ease of implementation and use.
Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, according to Frost & Sullivan’s recent analysis, Global Prenatal Genetic Testing Industry. Physicians’ emphasis on tests for children and parents in regular clinical consultations has further accelerated the industry’s growth. The global market for prenatal genetic testing is expected to reach $11.39 billion by 2026 from $8.08 billion in 2021, registering expansion at a compound annual growth rate (CAGR) of 7.1%.
Based on its recent analysis of the global decentralized clinical trials (DCT) industry, Frost & Sullivan has recognized leading global clinical research organization (CRO) Parexel with the 2022 Global Customer Value Leadership Award. Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while ensuring the highest levels of patient safety. The company offers Phase I-IV clinical trial capabilities, integrated consulting expertise, and broad therapeutic expertise to accelerate new therapies for patients.
Read more
